Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05591573
Other study ID # SSSU
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 31, 2022
Est. completion date April 30, 2023

Study information

Verified date March 2024
Source Swansea University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will test whether the consumption of a low versus a high glycemic index pre-bed drink influences sleep architecture, memory consolidation, nocturnal glucose metabolism, and mood.


Description:

Few studies have examined the impact of meal composition on sleep. Most research has focused on carbohydrate intake, although reports are sporadic and confounded by the manipulation of other macronutrients. Nonetheless, the pattern of results appears to depend on the nature of the sleep variable under investigation e.g., latency, duration, or efficiency. The study will determine whether manipulating the glycemic index of a pre-bed drink influences sleep architecture, procedural and declarative memory consolidation, nocturnal glucose metabolism, and mood. Participants will stay in the sleep laboratory for three nights, each night separated by one week (visit 1, 2, and 3). The first night is an acclimatisation night. The same procedure will be followed on all three nights, as described below. On the morning of each visit, a continuous glucose monitor will be set up and worn until 8pm the following evening. Participants will be asked to return to the sleep laboratory at 7pm, having fasted for five hours, and asked to consume a standardised evening meal. Several mood questionnaires will be completed throughout the evening and a polysomnography will be set up. Two memory tasks will be administered at approximately 10pm. Immediately after this, participants will consume either water (night 1), or a low glycemic index or high glycemic index drink (night 2 or 3). Participants will retire to bed at approximately 11pm and woken up between 6.30am - 8am, depending on personal preference. In the morning, the memory tasks will be administered again, as well as two mood questionnaires. Participants will be asked to wear a Pro-Diary watch throughout the day, which measures mood and hunger. At 8pm, both the continuous glucose monitor and Pro-diary watch will be collected from the participant.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date April 30, 2023
Est. primary completion date April 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Male (given that the menstrual cycle may influence sleep polysomnography) - Good health - Not taking any medication known to effect sleep or metabolism - Normal sleep duration (i.e. between 6.5 - 9 hours of sleep per night) - A sleep efficiency score above 80% (Pittsburg Sleep Quality Index) - Normal sleep schedule (i.e. fall asleep between 10pm and 12pm) - No difficulty sleeping in new places Exclusion Criteria: - Diagnosis of any physical or mental disorder e.g. diabetes, cardiovascular disorders, gastrointestinal disorders, sleep problems, epilepsy, or mood disorders - Unhealthy weight (BMI over 30) - Drink more than 300mg of caffeine per day (3 - 4 standard sized 8-oz cups) - Work nights or shifts - Smoke/vape - Regularly drink alcohol (>3 glasses per day) - Used recreational drugs within the last 6 months - Take part in >3 hours of vigorous exercise per week - Any known food allergies or intolerances - Nocturnal eating or regular consumption of alcohol before bed (assessed by the Meal Pattern Questionnaire)

Study Design


Intervention

Dietary Supplement:
Low glycemic index drink
Fruit flavoured drink with low glycemic index sugar (300 ml)
High glycemic index drink
Fruit flavoured drink with high glycemic index sugar (300 ml)

Locations

Country Name City State
United Kingdom Swansea University Swansea West Glamorgan

Sponsors (1)

Lead Sponsor Collaborator
Swansea University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sleep onset latency (polysomnography) Onset of sleep from the time the lights are turned off. Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Primary Total sleep time (polysomnography) The total number of hours of sleep. Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Primary Wake after sleep onset (polysomnography) Hours of wake time after three epochs of sleep have occurred. Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Primary Sleep efficiency (polysomnography) Total sleep time divided by the time from lights out until awakening in the morning. Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Primary Sleep stages (polysomnography) Time spent in each sleep stage. Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Primary Arousal index (polysomnography) Number of arousals throughout the night. Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Primary Leeds Sleep Evaluation Questionnaire Subjective assessment of sleep quality. Scores range from 0 to 30. Higher scores indicate poorer sleep quality. Administered 10 - 20 minutes after waking up in the morning,
Secondary Glucose response (continuous glucose monitor) The 2h and 3h incremental area under the curve (iAUC) will be used to assess glycemic response to the pre-bed drink. The mean amplitude of glycemic excursion (MAGE) will be assessed as an indicator for glycemic variability during the night and for 25 hours. 25 hours during night 2 and night 3 (weeks 2 and 3)
Secondary Finger tapping task (procedural memory) The change in performance from the learning phase to the recall phase. Completed at 10pm, and between 6.30 - 8am the following morning, on night 2 and night 3 (week 2 and 3).
Secondary Story recall task (declarative memory) The number of content words (nouns, adjectives, and verbs) correctly recalled. Completed at 10pm, and between 6.30 - 8am the following morning, on night 2 and night 3 (week 2 and 3).
Secondary Epworth Sleepiness Scale Subjective assessment of daytime sleepiness. Scores range from 0 - 24. Higher scores indicate more daytime sleepiness. Administered at 8pm on the evening after night 2 and night 3 (week 2 and 3).
Secondary Mood and hunger Scores range from 0 - 100. Higher scores indicate stronger feelings. Completed five times throughout the evening and twice in the morning (immediately after waking up and 20-30 minutes later) on night 2 and night 3 (week 2 and 3). .
Secondary Mood Pro-diary watch Prompted from 9.30am - 5.30pm after night 2 and night 3 (week 2 and 3).
Secondary Actigraphy Time spent in each sleep stage. Night 2 and night 3 (week 2 and 3).
See also
  Status Clinical Trial Phase
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT03708692 - Menstrual Cycle Phases on Recovery and Cognitive Function
Active, not recruiting NCT04505345 - Virtual Reality Cognitive Training in Alcohol Use Disorder N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT02915913 - Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults N/A
Completed NCT01410097 - Physical and Cognitive Function - Look AHEAD Ancillary Study N/A
Completed NCT03826121 - Efficacy and Safety of Sesame Oil Cake Extract on Improvement of Cognitive Function N/A
Recruiting NCT05621278 - Children to Adults Mental and Psychosomatic Health Study (CAMPS)
Completed NCT05498415 - Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study N/A
Completed NCT03208569 - Anticholinergic Burden - Treatment Optimization
Completed NCT03793777 - The Effect of Aronia Melanocarpa Extract on Cognitive Function N/A
Recruiting NCT05525299 - Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors N/A
Completed NCT03698123 - Performance Nutrition for Residents and Fellows N/A
Completed NCT04543500 - Self-regulation of Prefrontal Cortex During Emotional Cognitive Control N/A
Recruiting NCT05891977 - Effect of Tomato Paste Consumption on the Microbiota-gut-brain Axis in Healthy Adults N/A
Recruiting NCT05591885 - Nutrilite Memory Builder on the Improvement of Cognitive Function N/A
Active, not recruiting NCT05575752 - Acute Health Effects of High Temperature Exposure N/A
Completed NCT03716609 - Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function N/A
Completed NCT02763514 - The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood N/A
Completed NCT02675621 - Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults N/A